Three important studies published in the Journal during the past 3 years have addressed key issues
related to prostate cancer. Two articles described large trials of prostate-specific antigen
(PSA) screening and reached opposite conclusions regarding the impact of screening on the
risk of death from prostate cancer.
[swfobj src=”https://medicinainternaelsalvador.com/wp-content/uploads/2012/07/cadeprostata.swf” width=”700″ height=”500″ align=”center” allowfullscreen=”true”]